COLLEGIUM PHARMACEUTICAL INC's ticker is COLL and the CUSIP is 19459J104. A total of 138 filers reported holding COLLEGIUM PHARMACEUTICAL INC in Q4 2020. The put-call ratio across all filers is 0.88 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $401,406 | +17.9% | 17,960 | +13.4% | 0.00% | – |
Q2 2023 | $340,423 | -16.8% | 15,841 | -7.1% | 0.00% | – |
Q1 2023 | $409,245 | -0.2% | 17,059 | -3.5% | 0.00% | – |
Q4 2022 | $410,014 | +44.4% | 17,673 | -0.2% | 0.00% | – |
Q3 2022 | $284,000 | -0.4% | 17,701 | +9.9% | 0.00% | – |
Q2 2022 | $285,000 | -12.6% | 16,102 | +0.5% | 0.00% | – |
Q1 2022 | $326,000 | +34.7% | 16,028 | +23.6% | 0.00% | – |
Q4 2021 | $242,000 | -29.2% | 12,970 | -25.1% | 0.00% | – |
Q3 2021 | $342,000 | -1.4% | 17,310 | +17.9% | 0.00% | – |
Q2 2021 | $347,000 | +4.2% | 14,679 | +4.4% | 0.00% | – |
Q1 2021 | $333,000 | +16.0% | 14,058 | -1.8% | 0.00% | – |
Q4 2020 | $287,000 | +24.8% | 14,316 | +29.8% | 0.00% | – |
Q3 2020 | $230,000 | +21.1% | 11,027 | +1.6% | 0.00% | – |
Q2 2020 | $190,000 | +13.8% | 10,854 | +6.2% | 0.00% | – |
Q1 2020 | $167,000 | +16600.0% | 10,224 | +14505.7% | 0.00% | – |
Q1 2017 | $1,000 | 0.0% | 70 | 0.0% | 0.00% | – |
Q4 2016 | $1,000 | – | 70 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Rubric Capital Management LP | 2,606,500 | $51,452,000 | 1.44% |
Camber Capital Management LP | 2,000,000 | $39,480,000 | 1.22% |
Eventide Asset Management | 2,629,593 | $51,908,000 | 0.68% |
GREAT POINT PARTNERS LLC | 121,342 | $2,395,000 | 0.56% |
RICE HALL JAMES & ASSOCIATES, LLC | 753,038 | $14,865,000 | 0.55% |
Values First Advisors, Inc. | 41,773 | $825,000 | 0.53% |
CLARK ESTATES INC/NY | 183,800 | $3,628,000 | 0.52% |
EMERALD MUTUAL FUND ADVISERS TRUST | 710,398 | $14,023,000 | 0.48% |
EMERALD ADVISERS, LLC | 590,256 | $11,652,000 | 0.42% |
ACORN FINANCIAL ADVISORY SERVICES INC /ADV | 68,812 | $1,358,000 | 0.42% |